AbbVie has tapped North Carolina as the location for a new $1.4bn manufacturing site as part of its $100bn US manufacturing pledge – adding another giant to the growing list of pharma companies ramping up their presence in the state. With this investment, the largest in a single campus in AbbVie's history, the Illinois-based pharma will build an 185-acre site to produce its range of oncology, immunology, and neuroscience therapies. Located close to Research Triangle Park, a key life sciences hub in the stat ...